EGFL7 Antibodies

Santa Cruz Biotechnology delivers a wide array of EGFL7 monoclonal antibodies for research focused on understanding EGFL7 protein functions. EGFL7 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).EGFL7, or Epidermal Growth Factor-Like Domain 7, is a secreted protein that plays a crucial role in angiogenesis and vascular development. EGFL7 regulates endothelial cell behavior and influences various physiological and pathological processes, including tumor growth and metastasis. Research has shown that EGFL7 expression patterns vary significantly across different tissue types and developmental stages. Understanding EGFL7 function is essential for advancing therapeutic strategies in cancer and cardiovascular diseases. Current studies indicate that EGFL7 may serve as a potential therapeutic target in various pathological conditions. Ongoing research continues to uncover new aspects of EGFL7's biological significance and its impact on disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EGFL7's role in health and disease.